Wouldn’t mind being there, because Rennie
will likely use this forum to announce a go
ahead from FDA to proceed with 2x2 dosing
for P3, without any strings attached and permission
by TGA to proceed with DMOAD submission.
Also, an immediate $100M upfront payment
from J&J with 25% royalty from marketing
Zilosul, post regulatory approval. I would have
preferred CSL to keep it Aussie, but beggars
can’t be choosers.
We will also hear about the many Pharma
companies (big and small) who were vying
for a piece of the action.
Yeh, right.
Wouldn’t mind being there, because Renniewill likely use this...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.015(7.50%) |
Mkt cap ! $75.30M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.0¢ | $175.5K | 833.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 8334 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |